Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease which usually follows a monophasic course. Autoreactive T h 1 CD4 ⍣ T cells are responsible for the lesions, whereas autoreactive T h 2 CD4 ⍣ T cells can, upon adoptive transfer, suppress the disease process. However, the role of IL-4 and T h 2 cells in the spontaneous remission of EAE and in the prevention of relapses is not known. We have addressed these issues using IL-4-deficient mice in which the differentiation of T h 2 CD4 ⍣ T cells is severely compromised. The clinical course of actively induced EAE was compared in IL-4⍣/⍣, IL-4⍣/-and IL-4-/-mice on the PL/J genetic background. No significant differences were noted between groups for the frequency, severity and duration of EAE, and the frequency of relapses. Our results indicate that IL-4, despite its welldocumented regulatory role in EAE, is not necessary for the spontaneous remission of disease or for the prevention of relapses. Therefore, in the absence of IL-4, overlapping or compensatory immunoregulatory mechanisms can restrict an inflammatory response within the central nervous system.
Following antigenic stimulation, CD4 ϩ T helper cells differentisystemic autoimmune diseases (9), whereas autoreactive T h 1 cells are pathogenic in several models of organ-specific ate into functionally distinct subsets characterized by the pattern of lymphokines they produce: T h 0, T h 1 and T h 2 autoimmune diseases including experimental autoimune encephalomylitis (EAE) (10). CD4 ϩ T cells. Several parameters influence CD4 ϩ T cell differentiation: the dose of antigen, the type of antigen-EAE is an inflammatory disease of the central nervous system (CNS) that serves as an animal model for multiple presenting cells, the type of co-stimulatory signals, MHC as well as non-MHC genetic factors (1) (2) (3) (4) (5) . However, the best sclerosis. In adoptive transfer experiments, autoreactive CD4 ϩ T cells specific for myelin antigens such as myelin basic characterized factors involved in T h subset development are the cytokines (1). In particular, IL-12 drives the differentiation protein (MBP) or proteolipid protein (PLP) can induce EAE. It is now clear that the induction of CNS lesions correlates with of T h 1 cells (6), whereas IL-4 strongly supports the development of T h 2 CD4 ϩ T cells as shown in vitro and in vivo by the in situ production of type 1 cytokines and that EAE can be adoptively transferred to naive animals by MBP-or PLPeffect of neutralizing anti-IL-4 mAb and by analysis of mice with a disrupted IL-4 gene (7,8). The relevance of this specific T h 1 CD4 ϩ T cell clones (11-13). Interestingly, autoreactive T h 2 CD4 ϩ T cell clones, sharing the fine specificity of functional division in vivo has been confirmed in situations involving persistent antigenic stimulation such as infections encephalitogenic T h 1 clones could not transfer disease (12,13). Furthermore, spontaneous recovery from EAE is (e.g. Leishmania major) and atopic or autoimmune diseases. Indeed, a polarized T h 2 response seems to be implicated in associated with an increased production of IL-4 in the CNS a IL-4ϩ/ϩ (n ϭ 16), IL-4ϩ/-(n ϭ 22) and IL-4-/-(n ϭ 25) littermates (6-12 weeks of age) were immunized and followed as described in Fig. 2 . Delay before onset, maximum score and mean duration were compared using the non-parametric Mann-Whitney U-test. Disease incidence, fatality and relapse rates were compared using the χ 2 or Fischer exact tests.
b No statistical differences when compared to IL-4ϩ/ϩ or IL-4ϩ/-mice. c P Ͻ 0.05 when compared to IL-4ϩ/-or pooled IL-4ϩ/ϩ and IL-4ϩ/-mice.
genotype of the PL/J backcrossed mice could be assessed of the parasites is T h 2 dependant (30) . Similarly, IL-4-deficient BALB/c mice remain susceptible to Leishmania major infection by Southern blot analysis of the IL-4 locus using BglII-digested tail DNA as shown in Fig. 1 . At each generation the IL-4
indicating that IL-4 is not, by itself, responsible for the susceptibility of this mouse strain (31). Conversly, IL-4-/-genotype of each individual was assessed. Progeny derived from intercrossing IL-4 heterozygous mice on their second mice fail to develop experimental onchocercal keratitis indicating that T h 2 T cells are essential for the immunopathogenesis backcross on the PL/J background were used for EAE experiments.
of this corneal disease (32) . The precise mechanisms underlying spontaneous downWe have compared the severity of EAE induced by active immunization with mouse spinal cord homogenate in IL-4-/-, modulation of the inflammatory process in EAE, as well as prevention of relapses, remain mostly unknown. There is IL-4ϩ/-and IL-4ϩ/ϩ littermates. The clinical course of the disease over a 50 day period, in two such experiments, is strong evidence for a role of IL-4 and IL-4-driven T h 2 responses being part of a natural suppressor mechanism of shown in Fig. 2 . The presence of a homozygous mutation in the IL-4 gene does not significantly affect the severity of the EAE, although this regulatory pathway has not been formally demonstrated in vivo. Supporting this hypothesis are reports disease. Indeed, as summarized in Table 1 , the incidence of EAE, the delay before onset, the maximum clinical score and correlating genetic resistance to EAE with preferential development of autoreactive T cells of the T h 2 phenotype (2,15). the mortality rate (all indicative of the severity of the disease) were similar in IL-4-/-mice and their heterozygous or wildIn addition, it is interesting to note that two of the chromosomal regions implicated in the MHC-independent genetic susceptitype littermates. Duration of the disease tended to be longer in IL-4-/-mice compared to pooled IL-4ϩ/ϩ and IL-4ϩ/-bility to relapsing EAE in Biozzi mice contain the IL-4 and IL-4 receptor genes (33) . Furthermore, whereas IL-4 is undetectmice, although the difference was no longer significant after statistical correction for multiple comparisons. Therefore, the able by immunohistochemistry in the CNS at the peak of EAE, natural recovery correlates well with expression of this cytokine absence of endogenous IL-4 has no major consequences on the spontaneous termination of the disease. Furthermore, in the brain (14). Racke et al. (21) have shown that pretreatment of MBP-specific lymph node T cells with anti-IL-4 relapse incidence was not increased in IL-4-/-mice, indicating that IL-4 is dispensable for the prevention of relapses. Of mAb in vitro greatly enhances their pathogenic potential. However, to our knowledge, there is no report on the in vivo note, the frequency and severity of EAE in these genetically heterogenous mice were not statistically different from that of treatment with anti-IL-4 mAb during the induction phase of active EAE, although neutralizing anti-IL-4 mAb did not control PL/J mice immunized in parallel, suggesting that most of the relevant EAE-susceptibility genes were transmitted after exacerbate the clinical severity of passively transferred EAE (18). two backcrosses on the PL/J background (data not shown).
Collectively, these data suggest that IL-4-driven T h 2 In contrast, the role of IL-4 and autoreactive T h 2 responses as therapeutical down-regulators of EAE has been firmly responses are not required for the naturally occuring downregulation of the disease process or for the prevention of established. Firstly, MBP-specific T cells grown in IL-4 have reduced pathogenic potential and i.p. injections of IL-4 after relapses. Similarly, using IL-4-/-mice Garside et al. (28) have argued that T h 2 cells are not required for the induction of oral adoptive transfer of MBP-specific T cells markedly reduce clinical severity of EAE (21). Furthermore, IL-4-secreting autotolerance with a high-dose of antigen, although mucosal immune responses are severely impaired in these mice (29) .
reactive T cells can transfer protection against EAE. Indeed, MBP-specific CD4 ϩ clones that secrete high levels of IL-4 IL-4-/-mice have been used to assess the involvement of T h 2 cells not only in tolerance induction but also in resistance and IL-10, but no IFN-γ, derived from orally tolerized mice, were able to reduce the clinical and histopathological features to a variety of infectious agents. The absence of IL-4 has little effect on the course of infection with the nematodes Brugia of both MBP-and PLP-induced EAE (24) . Similarly, mice immunized with PLP peptide and treated with anti-B7-1 mAb malayi and Nippostrongylus brasiliensis although clearance is unlikely since its production is defective in IL-4-/-mice (8). not yet been assessed in IL-4-/-mice.
